Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of ensifentrine in Chronic Obstructive Pulmonary Disease has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ensifentrine (ensifentrine)

Snippet

Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-11-13